Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1’621 INR | +1.02% | +3.54% | +28.67% |
19.03. | Cosmo erhält Zulassung für Winlevi in Australien | AW |
19.03. | Cosmo Pharmaceuticals Partner erhält behördliche Zulassung für Aknebehandlung in Australien | MT |
ETFs investiert in Sun Pharmaceutical Industries Ltd.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
1,72% | 6 M€ | +6.07% | - | |
0,42% | 18 M€ | +4.25% | ||
0,20% | 2 761 M€ | +4.96% | - | |
0,20% | 429 M€ | +3.32% | - | |
0,20% | 147 M€ | +2.32% | - | |
0,20% | 1 M€ | +3.49% | - | |
0,20% | 3 M€ | -.--% | - | |
0,17% | 4 M€ | -4.41% | - | |
0,13% | 115 M€ | +5.14% | - | |
0,11% | 11 M€ | +2.19% | ||
0,08% | 30 M€ | +5.59% | - | |
0,05% | 0 M€ | 0.00% | - | |
0,05% | 7 M€ | +4.29% | - | |
0,05% | 5 M€ | +15.05% | - | |
0,03% | 15 M€ | +8.65% | ||
0,02% | 36 M€ | +4.92% | - | |
0,02% | 31 M€ | +8.30% | - | |
0,02% | 367 M€ | +8.59% | - | |
0,02% | 38 M€ | +6.05% | - | |
0,02% | 286 M€ | +6.29% | - | |
0,01% | 105 M€ | +4.11% | - | |
0,01% | 17 M€ | -0.46% | ||
0,01% | 22 M€ | +3.34% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+28.67% | 46.63 Mrd. | |
+19.30% | 22.49 Mrd. | |
+20.11% | 14.49 Mrd. | |
+0.55% | 12.98 Mrd. | |
+46.16% | 12.16 Mrd. | |
-2.44% | 7.69 Mrd. | |
-0.05% | 6.79 Mrd. | |
-8.87% | 5.73 Mrd. | |
+7.80% | 5.15 Mrd. | |
-0.87% | 4.64 Mrd. |
- Börse
- Aktien
- Aktie Sun Pharmaceutical Industries Ltd. - NSE India S.E.
- ETFs Sun Pharmaceutical Industries Ltd.